Perseris (risperidone) won approval from the US Food and Drug Administration (FDA), making it the first once-monthly long-acting injectable (LAI) for the illness. It will be particularly ...

Indivior, leader in opioid treatment, trades near 52-week lows. Read more on INDV stock's financials, growth challenges, and ...

Purpose: The pharmacology, pharmaceutics, clinical efficacy, adverse effects, cost, and dosage and administration of long-acting risperidone injection are reviewed. Summary: Risperidone is the ...